Updated
Updated · creators.yahoo.com · Apr 25
Brian Nwannunu advises GLP-1 drug users on protecting bone and muscle health
Updated
Updated · creators.yahoo.com · Apr 25

Brian Nwannunu advises GLP-1 drug users on protecting bone and muscle health

4 articles · Updated · creators.yahoo.com · Apr 25
  • Dr. Nwannunu, an orthopedic surgeon at Texas Joint Institute, highlights risks for millions using Ozempic, Wegovy, and Mounjaro, especially postmenopausal women and older adults vulnerable to osteoporosis and muscle loss.
  • He recommends protein intake monitoring, resistance training, and regular lab checks to preserve bone density and muscle mass, cautioning against unnecessary supplements or scans without clinical need.
  • While GLP-1 drugs can reduce joint pain and surgical needs, Nwannunu warns of long-term risks like osteoporosis and urges ongoing patient-provider discussions to individualize treatment and avoid one-size-fits-all approaches.
Could GLP-1 drugs actually reverse osteoarthritis, making bone-thinning risks a worthwhile trade-off?
Ozempic relieves joint pain but may cause fractures. Is this drug trading one health crisis for another?
Doctors list four 'non-negotiable' steps for GLP-1 users. Are you doing enough to protect your bones?
Are we creating a future osteoporosis epidemic by treating obesity with these medications today?
For older adults on Wegovy, how can you tell if you are losing dangerous muscle instead of just fat?

Balancing Benefits and Risks: Managing the 29% Increased Osteoporosis Risk with GLP-1 Receptor Agonists in Obesity and Diabetes Treatment

Overview

The global rise in obesity and type 2 diabetes is driving increased risks of musculoskeletal conditions like osteoarthritis and complicating joint surgeries. GLP-1 receptor agonists (GLP-1 RAs) effectively promote weight loss and improve metabolic health, offering short-term benefits such as better surgical outcomes and fewer complications. However, rapid weight loss from these drugs also causes muscle loss, which reduces mechanical support for bones, leading to decreased bone density and higher risks of osteoporosis, gout, and osteomalacia over time. These risks are especially pronounced in older adults and postmenopausal women. Careful, personalized management is essential to balance the benefits of GLP-1 RAs with protection of muscle and bone health.

...